Vaccine Contract Manufacturing Market Size 2022-2027, Global Top Companies Analysis, In-Depth Insight, Business Opportunities And Forecast 2027 | Ajinomoto Co. Inc., Albany Molecular Research Inc, Catalent Inc, Cytovance Biologics Inc., Fujifilm Holdings

According to the latest report by IMARC Group, titled "Vaccine Contract Manufacturing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global vaccine contract manufacturing market size reached US$ 2.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2027, exhibiting a growth rate (CAGR) of 10.12% during 2022-2027.

Download a free sample report to get a detailed overview of the market: https://www.imarcgroup.com/vaccine-contract-manufacturing-market/requestsample

Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.

Vaccine Contract Manufacturing Market Outlook:

Vaccine contract manufacturing refers to the process of outsourcing large-scale production of vaccines to contract manufacturing organizations (CMOs). Pre-formulation work, method development, formulation development, pre-clinical activities, stability studies, registration batches, and commercial manufacturing are some of the services rendered by the organizations. Currently, reduced development costs and complex production protocols are escalating the demand for vaccine contract manufacturing activities.

Global Vaccine Contract Manufacturing Market Trends 2022-2027

The global market is primarily driven by the elevating consumer awareness towards vaccines to provide protection from severe illnesses and infectious diseases. Additionally, the increasing need for improving human and veterinary health, along with escalating demand for immunization programs and inoculations is also propelling the market growth.

Moreover, the lack of skilled labor and equipment for vaccine production in low-resource nations is contributing to the market growth. Additionally, several technological advancements, like the advent of expression systems, such as the EB66 and GPEx, and cell culture media platforms, are further augmenting the market growth.

Besides this, the sudden outbreak of COVID-19 cases has encouraged the vaccine developers to sign outsourcing agreements with CMOs to ramp up the overall production, which will create a positive outlook for market growth in the coming years.

You can buy this report directly (Exclusive offer on this report): https://www.imarcgroup.com/checkout?id=3872&method=1

Vaccine Contract Manufacturing Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players                                                            

The competitive landscape of the global vaccine contract manufacturing market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Ajinomoto Co. Inc.
• Albany Molecular Research Inc
• Catalent Inc
• Cobra Biologics Limited (Charles River Laboratories International Inc.)
• Cytovance Biologics Inc. (Hepalink USA Inc.)
• Fujifilm Holdings Corporation
• ICON plc
• IDT Biologika GmbH
• Lonza Group AG
• Merck KGaA
• Pharmaceutical Product Development LLC
• PRA Health Sciences Inc.

Key Market Segmentation:

The report has segmented the global vaccine contract manufacturing market on the basis of vaccine type, workflow, application and region.

Breakup by Vaccine Type:

• Attenuated
• Inactivated
• Subunit-based
• Toxoid-based
• DNA-based

Breakup by Workflow:

• Downstream
• Upstream

Breakup by Application:

• Human Use
• Veterinary

Geographical Analysis:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-contract-manufacturing-market

Key highlights of the report:               

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Industry Trends
• Market Drivers and Success Factors
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse More Reports:

Poultry Vaccines Market Opportunity and Forecast 2022-2027: https://www.imarcgroup.com/poultry-vaccines-market

Pet Supplement Market Growth, Opportunity and Forecast 2022-2027: https://www.imarcgroup.com/pet-supplement-market

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.